ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 241 filers reported holding ARRAY BIOPHARMA INC in Q1 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $12,342,000 | +78.5% | 266,400 | -6.1% | 0.02% | +66.7% |
Q1 2019 | $6,914,000 | +70.2% | 283,580 | -0.5% | 0.01% | +50.0% |
Q4 2018 | $4,063,000 | -13.6% | 285,128 | -7.8% | 0.01% | 0.0% |
Q3 2018 | $4,702,000 | -13.8% | 309,328 | -4.8% | 0.01% | -25.0% |
Q2 2018 | $5,454,000 | +15.8% | 325,058 | +12.6% | 0.01% | +14.3% |
Q1 2018 | $4,710,000 | +47.1% | 288,600 | +15.4% | 0.01% | +75.0% |
Q4 2017 | $3,201,000 | +8.2% | 250,100 | +4.0% | 0.00% | 0.0% |
Q3 2017 | $2,958,000 | +46.9% | 240,500 | 0.0% | 0.00% | +33.3% |
Q2 2017 | $2,013,000 | -11.7% | 240,500 | -5.7% | 0.00% | -25.0% |
Q1 2017 | $2,280,000 | +5.7% | 255,000 | +3.9% | 0.00% | 0.0% |
Q4 2016 | $2,158,000 | +14.8% | 245,500 | -11.8% | 0.00% | +33.3% |
Q3 2016 | $1,880,000 | +77.4% | 278,500 | -6.4% | 0.00% | +50.0% |
Q2 2016 | $1,060,000 | +17.0% | 297,700 | -3.0% | 0.00% | +100.0% |
Q1 2016 | $906,000 | -34.1% | 307,000 | -5.7% | 0.00% | -50.0% |
Q4 2015 | $1,374,000 | -7.4% | 325,500 | 0.0% | 0.00% | -33.3% |
Q3 2015 | $1,484,000 | -36.8% | 325,500 | 0.0% | 0.00% | -25.0% |
Q2 2015 | $2,347,000 | -5.6% | 325,500 | 0.0% | 0.00% | +33.3% |
Q1 2015 | $2,487,000 | 0.0% | 325,500 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $2,487,000 | +114.0% | 325,500 | 0.0% | 0.00% | +50.0% |
Q3 2014 | $1,162,000 | -21.7% | 325,500 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $1,484,000 | +7.5% | 325,500 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $1,380,000 | -10.0% | 325,500 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $1,533,000 | -25.5% | 325,500 | -1.6% | 0.00% | -50.0% |
Q3 2013 | $2,057,000 | +54.3% | 330,660 | +12.6% | 0.00% | +33.3% |
Q2 2013 | $1,333,000 | – | 293,560 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 16,618,776 | $146,079,000 | 12.59% |
BVF INC/IL | 4,986,186 | $43,829,000 | 8.81% |
First Light Asset Management, LLC | 1,000,361 | $8,793,000 | 3.86% |
Crosspoint Capital Strategies, LLC | 463,005 | $4,070,000 | 3.62% |
Consonance Capital Management LP | 2,723,471 | $23,912,000 | 2.63% |
KOPP INVESTMENT ADVISORS LLC | 219,926 | $1,933,000 | 2.04% |
SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $7,911,000 | 2.00% |
Orbimed Advisors | 16,088,800 | $141,421,000 | 1.80% |
Cormorant Asset Management, LP | 1,150,000 | $10,109,000 | 1.36% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,073,680 | $18,227,000 | 1.26% |